Codexis (CDXS) Total Current Liabilities (2010 - 2026)
Codexis (CDXS) posted quarterly Total Current Liabilities of $14.8 million for Q1 2026, down 28.95% year-over-year from $20.9 million in Q1 2025, and down 41.34% quarter-over-quarter from $25.3 million in Q4 2025.
Codexis (CDXS) Total Current Liabilities (2010 - 2026) Analysis & Trends
Codexis' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $14.8 million for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 28.95% year-over-year to $14.8 million; the TTM figure through Mar 2026 stood at $14.8 million (down 28.95% YoY), while the FY2025 annual figure was $25.3 million, up 7.06% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $14.8 million, down from $25.3 million in the prior quarter.
- The five-year high for Total Current Liabilities was $49.1 million in Q4 2022, with the low at $14.8 million in Q1 2026.
- The 5-year median for Total Current Liabilities is $30.0 million (2022), against an average of $29.5 million.
- The sharpest annual moves came in 2022 and 2025: Total Current Liabilities surged 47.03% in 2022, then sank 50.11% in 2025.
- Codexis' Total Current Liabilities stood at $49.1 million in 2022, then declined by 26.98% to $35.8 million in 2023, then sank by 34.0% to $23.6 million in 2024, then increased by 7.06% to $25.3 million in 2025, then tumbled by 41.34% to $14.8 million in 2026.
- Business Quant data shows CDXS's Total Current Liabilities at $14.8 million in Q1 2026, $25.3 million in Q4 2025, and $18.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.23 Bn | 132.38 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 86.97 Bn | 78.97 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 59.88 Bn | 54.74 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 42.20 Bn | 37.11 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.69 Bn | 10.30 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - | 630.93 Mn |
| 10 | Codexis | 146.14 Mn | 91.22 Mn | 11.40 Mn | 23.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.51 Mn |
| Mar 31, 2026 | 14.85 Mn |
| Dec 31, 2025 | 25.32 Mn |
| Sep 30, 2025 | 18.48 Mn |
| Jun 30, 2025 | 15.24 Mn |
| Mar 31, 2025 | 20.90 Mn |
| Dec 31, 2024 | 23.65 Mn |
| Sep 30, 2024 | 35.13 Mn |
| Jun 30, 2024 | 30.54 Mn |
| Mar 31, 2024 | 29.08 Mn |
| Dec 31, 2023 | 35.83 Mn |
| Sep 30, 2023 | 38.42 Mn |
| Jun 30, 2023 | 35.74 Mn |
| Mar 31, 2023 | 38.31 Mn |
| Dec 31, 2022 | 49.07 Mn |
| Sep 30, 2022 | 31.91 Mn |
| Jun 30, 2022 | 30.01 Mn |
| Mar 31, 2022 | 29.50 Mn |
| Dec 31, 2021 | 33.37 Mn |
| Sep 30, 2021 | 33.48 Mn |